Hoth Therapeutics, Inc., Voltron Therapeutics, Inc., & HaloVax Announce Selection of the First of Two Sets of Virus Targeting Peptides for Animal Testing in the Development of a COVID-19 Vaccine
About Hoth Therapeutics, Inc.
- NASDAQ: $HOTH
- Notified: $3.31
- 09:44 EDT
